Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Invested Capital (2016 - 2025)

Avanos Medical's Invested Capital history spans 12 years, with the latest figure at $1.4 billion for Q3 2024.

  • For Q3 2024, Invested Capital fell 6.63% year-over-year to $1.4 billion; the TTM value through Dec 2024 reached $589.0 million, down 57.8%, while the annual FY2023 figure was $1.4 billion, 8.03% down from the prior year.
  • Invested Capital for Q3 2024 was $1.4 billion at Avanos Medical, up from -$149.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.5 billion in Q3 2020 and bottomed at -$149.1 million in Q2 2024.
  • The 5-year median for Invested Capital is $1.4 billion (2023), against an average of $863.0 million.
  • The largest annual shift saw Invested Capital skyrocketed 4035.16% in 2021 before it plummeted 212.27% in 2024.
  • A 5-year view of Invested Capital shows it stood at $1.4 billion in 2020, then fell by 2.88% to $1.4 billion in 2021, then rose by 8.35% to $1.5 billion in 2022, then decreased by 8.03% to $1.4 billion in 2023, then fell by 0.96% to $1.4 billion in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Invested Capital are $1.4 billion (Q3 2024), -$149.1 million (Q2 2024), and $137.7 million (Q1 2024).